301246 Hubei Hongyuan Pharmaceutical Technology
- 13.66
- +0.39+2.94%
Hubei Hongyuan Pharmaceutical Technology News
Hongyuan Pharmaceutical: progress announcement on the repurchase of the company\'s shares
Hongyuan Pharmaceutical: Announcement on the pledge of some shares of the company\'s controlling shareholders and actual controllers
Hongyuan Pharmaceutical: Announcement on the expiration of the company\'s supervisors\' holdings reduction plan period and the results of the holdings reduction
Hongyuan Pharmaceutical: An indicative announcement on the listing and circulation of some shares already issued before the initial public offering
Hongyuan Pharmaceutical: Opinions of Minsheng Securities Co., Ltd. on the listing and circulation of some shares issued by Hubei Hongyuan Pharmaceutical Technology Co., Ltd. before the initial public offering
Hongyuan Pharmaceutical: progress announcement on the repurchase of the company\'s shares
Hongyuan Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Hongyuan Pharmaceutical: Announcement of Board Resolutions
Hongyuan Pharmaceutical: 2024 Semi-Annual Report
Hongyuan Pharmaceutical: Announcement of Supervisory Board Resolutions
Hongyuan Pharmaceutical: Special Report on the Deposit and Use of Funds Raised for the Semi-Annual Year 2024
Hongyuan Pharmaceutical: 2024 Semi-Annual Follow-up Report of Minsheng Securities Co., Ltd. on Hubei Hongyuan Pharmaceutical Technology Co., Ltd.
Hongyuan Pharmaceutical: 2024 Semi-Annual Report Summary
Hongyuan Pharmaceutical: Announcement on Accruing Credit Impairment Losses and Asset Impairment Losses for the Semi-Annual Period of 2024
Hubei Hongyuan Pharmaceutical Technology: Announcement regarding the progress of repurchasing company shares.
Hubei Hongyuan Pharmaceutical Technology: Announcement of Annual Equity Distribution Implementation in 2023
Hubei Hongyuan Pharmaceutical Technology: Announcement regarding the progress of repurchasing company shares.
Hubei Hongyuan Pharmaceutical Technology: Announcement regarding the progress of repurchasing company shares.
Hubei Hongyuan Pharmaceutical Technology: Pre-disclosure notice on reduction of company shareholding by company supervisors
Hubei Hongyuan Pharmaceutical Technology: May 16, 2024 Investor Relations Activity Record
Analysis
Price Target
No Data
No Data